NCT03054883View on ClinicalTrials.gov

Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

April 1, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Mantle Cell Lymphoma
All Listed Sponsors
collaborator

Ministry of Health, Czech Republic

OTHER_GOV

lead

Czech Lymphoma Study Group

OTHER

NCT03054883 - Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy | Biotech Hunter | Biotech Hunter